Latest Ortho-McNeil Pharmaceutical Stories
Whistleblower law firm Young Law Group expects awards to relators in qui tam litigation to finish in the top five. Philadelphia, PA (PRWEB) May 20, 2014
LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news.
The DrugRisk Resource Center is the Web’s largest source for information on prescription drug research, side effects and legal news.
TITUSVILLE, N.J., June 17, 2011 /PRNewswire/ -- Ortho-McNeil-Janssen Pharmaceuticals, Inc. is initiating a voluntary recall of one lot of RISPERDALÂ® (risperidone) 3mg Tablets, marketed by Janssen Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
MHPA to engage health plans on most effective strategies to improve outcomes for Medicaid patients with severe mental illness WASHINGTON, May 4, 2011 /PRNewswire-USNewswire/ -- The Center for Best Practices, a new affiliate organization of Medicaid Health Plans of America (MHPA), today announced the receipt of financial sponsorship from Raritan, NJ-based pharmaceutical company Ortho-McNeil-Janssen Pharmaceuticals, Inc.
PARSIPPANY, N.J., May 2, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc.